| COMMON NAME |
AN100226,AN100226,BG00002 |
|---|---|
| SYNONYMS |
CD49D;IA4 |
| APPLICATIONS |
Flow Cyt |
| RECOMMENDED DILUTIONS |
Flow Cyt 1:10 |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| HOST SPECIES |
Humanized |
| IGG TYPE |
IgG4 |
| REACTIVITY |
Human |
| TARGET | |
| UNIPROT ID |
P13612 |
| DESCRIPTION |
Anti-ITGA4(natalizumab biosimilar) mAb |
| DELIVERY |
In Stock |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):BME100074
Anti-ITGA4（natalizumab biosimilar） mAb
Anti-ITGA4（natalizumab biosimilar） mAb
PRODUCT DATA
IMAGES
Figure 1. Anti-ITGA4 (natalizumab biosimilar) mAb on SDS-PAGE under non-reducing (NR) and reducing (R) conditions.
Figure 1. Flow cytometry analysis with 15 μg/mL Anti-ITGA4 (natalizumab) mAb (BME100074) on Expi293 cells transfected with Human ITGA4 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
